POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE

被引:2
|
作者
Das, Vidyanand [1 ]
Singh, Dharmendra [2 ]
Murti, Krishna [3 ]
Das, Sushmita [2 ]
Das, Pradeep [2 ]
Pandey, Krishna [1 ]
机构
[1] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Clin Med, Patna 800007, Bihar, India
[2] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna, Bihar, India
[3] Natl Inst Pharm & Educ Res, Dept Pharm Practice, Hajipur, Bihar, India
关键词
PKDL; VL; Miltefosine; Ulcer; Kala-Azar Elimination Program;
D O I
10.3844/ajidsp.2014.50.55
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Visceral Leishmaniasis (VL) or Kala-Azar (KA) is highly endemic in the Indian subcontinent particularly in Bihar. Post Kala-azar Dermal Leishmaniasis (PKDL) is a known reservoir for leishmania parasites for transmission of VL. The kala-azar elimination program was launched by the government of three countries of the Indian subcontinent in the year 2005, which aims to eliminate kala-azar by 2015 and PKDL by 2018. PKDL diagnosis and management has not been addressed properly. In this case report we have described a case of PKDL with ulcer and atypical presentation who was subsequently diagnosed by demonstration of Leishmania donovani bodies in the skin snips through microscopy, kinetoplast-DNA nested PCR and clinically. The patient was treated with miltefosine capsules in the dose of 50 mg twice-aday for twelve-weeks and responded completely. This case report assumes great importance as prompt diagnosis and treatment of PKDL is essential in the kala-azar elimination program.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 50 条
  • [1] Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
    Abongomera, Charles
    Battaglioli, Tullia
    Adera, Cherinet
    Ritmeijer, Koert
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 221 - 224
  • [2] Immune Responses in Post Kala-azar Dermal Leishmaniasis
    Chatterjee, Mitali
    Sengupta, Ritika
    Mukhopadhyay, Debanjan
    Mukherjee, Shibabrata
    Dighal, Aishwarya
    Moulik, Srija
    Sengupta, Shilpa
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (06) : 452 - 460
  • [3] Keratitis occurring in patients treated with miltefosine for post-kala-azar dermal leishmaniasis
    Kusumesh, Rakhi
    Ambasta, Anita
    Arya, Lalan Kumar
    Mohan, Nilesh
    Sinha, Bibhuti Prassan
    Ravidas, Vidyanand
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1497 - 1503
  • [4] Post-kala-azar Dermal Leishmaniasis: Facing the Challenge of Eliminating Kala-Azar from South Asia
    Desjeux, Philippe
    Ramesh, V.
    KALA AZAR IN SOUTH ASIA: CURRENT STATUS AND CHALLENGES AHEAD, 2011, : 111 - 124
  • [5] Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis
    Ramesh, V
    Dixit, Keerti Kaumudee
    Sharma, Neha
    Singh, Ruchi
    Salotra, Poonam
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (04) : 608 - 617
  • [6] Post-kala-azar Dermal Leishmaniasis with Mucosal Involvement: An Unusual Case Presentation including Successful Treatment with Miltefosine
    Salam, Md A.
    Siddiqui, Muhammad A.
    Nabi, Shah G.
    Bhaskar, Khondaker R. H.
    Mondal, Dinesh
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2013, 31 (02) : 294 - 297
  • [7] Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment
    Maruf, Shomik
    Nath, Proggananda
    Islam, Muhammad Rafiqul
    Aktar, Fatima
    Anuwarul, Azim
    Mondal, Dinesh
    Basher, Ariful
    PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (09):
  • [8] Laryngeal involvement during post kala-azar dermal leishmaniasis in India
    Nandy, A
    Addy, M
    Banerjee, D
    Guha, SK
    Maji, AK
    Saha, AM
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (04) : 371 - 373
  • [9] AmBisome for Kala-azar and Post-kala-azar Dermal Leishmaniasis: An Essential Option but Not a Universal Solution Reply
    den Boer, Margriet
    Burza, Sakib
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 190 - 190
  • [10] Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients
    Mohamed A M Salih
    Michaela Fakiola
    Mohamed H Abdelraheem
    Brima M Younis
    Ahmed M Musa
    Ahmed M ElHassan
    Jenefer M Blackwell
    Muntaser E Ibrahim
    Hiba S Mohamed
    BMC Infectious Diseases, 14